1. Home
  2. PLRX vs HKD Comparison

PLRX vs HKD Comparison

Compare PLRX & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • HKD
  • Stock Information
  • Founded
  • PLRX 2015
  • HKD 2003
  • Country
  • PLRX United States
  • HKD France
  • Employees
  • PLRX N/A
  • HKD N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • HKD Finance: Consumer Services
  • Sector
  • PLRX Health Care
  • HKD Finance
  • Exchange
  • PLRX Nasdaq
  • HKD Nasdaq
  • Market Cap
  • PLRX 641.5M
  • HKD 595.6M
  • IPO Year
  • PLRX 2020
  • HKD 2022
  • Fundamental
  • Price
  • PLRX $12.04
  • HKD $2.61
  • Analyst Decision
  • PLRX Strong Buy
  • HKD
  • Analyst Count
  • PLRX 7
  • HKD 0
  • Target Price
  • PLRX $40.50
  • HKD N/A
  • AVG Volume (30 Days)
  • PLRX 557.6K
  • HKD 418.2K
  • Earning Date
  • PLRX 02-26-2025
  • HKD 01-01-0001
  • Dividend Yield
  • PLRX N/A
  • HKD N/A
  • EPS Growth
  • PLRX N/A
  • HKD N/A
  • EPS
  • PLRX N/A
  • HKD 0.33
  • Revenue
  • PLRX N/A
  • HKD $27,776,448.00
  • Revenue This Year
  • PLRX N/A
  • HKD N/A
  • Revenue Next Year
  • PLRX N/A
  • HKD N/A
  • P/E Ratio
  • PLRX N/A
  • HKD $8.01
  • Revenue Growth
  • PLRX N/A
  • HKD N/A
  • 52 Week Low
  • PLRX $10.22
  • HKD $2.55
  • 52 Week High
  • PLRX $18.92
  • HKD $5.80
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 38.65
  • HKD 37.16
  • Support Level
  • PLRX $12.40
  • HKD $2.78
  • Resistance Level
  • PLRX $13.71
  • HKD $3.06
  • Average True Range (ATR)
  • PLRX 0.75
  • HKD 0.20
  • MACD
  • PLRX -0.11
  • HKD 0.01
  • Stochastic Oscillator
  • PLRX 10.23
  • HKD 7.50

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.

Share on Social Networks: